JCJoanna Czulak

Joanna Czulak

*This is an algorithmically generated author record based on publicly available information.

Joanna Czulak has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecularly Imprinted Polymer Nanoparticles Enable Rapid, Reliable, and Robust Point-of-Care Thermal Detection of SARS-CoV-2

    by Jake McClements, Laure Bar, Pankaj Singla, Francesco Canfarotta, Alan Thomson, Joanna Czulak, Rhiannon E. Johnson, Robert D. Crapnell, Craig E. Banks, Brendan Payne, et al.

    Rapid antigen tests are currently used for population screening of COVID-19. However, they lack sensitivity and utilize antibodies as receptors, which can only function in narrow temperature and pH ranges. Consequently, molecularly imprinted polymer nanoparticles (nanoMIPs) are synthetized with a fast (2 h) and scalable process using merely a tiny SARS-CoV-2 fragment (∼10 amino acids). The nanoMIPs rival the affinity of SARS-CoV-2 antibodies under standard testing conditions and surpass them at elevated temperatures or in acidic media. Therefore, nanoMIP sensors possess clear advantages over antibody-based assays as they can function in various challenging media. A thermal assay is developed with nanoMIPs electrografted onto screen-printed electrodes to accurately quantify SARS-CoV-2 antigens. Heat transfer-based measurements demonstrate superior detection limits compared to commercial rapid antigen tests and most antigen tests from the literature for both the alpha (∼9.9 fg mL–1) and delta (∼6.1 fg mL–1) variants of the spike protein. A prototype assay is developed, which can rapidly (∼15 min) validate clinical patient samples with excellent sensitivity and specificity. The straightforward epitope imprinting method and high robustness of nanoMIPs produce a SARS-CoV-2 sensor with significant commercial potential for population screening, in addition to the possibility of measurements in diagnostically challenging environments.


  • Immobilization of Molecularly Imprinted Polymer Nanoparticles onto Surfaces Using Different Strategies: Evaluating the Influence of the Functionalized Interface on the Performance of a Thermal Assay for the Detection of the Cardiac Biomarker Troponin I

    by Jake McClements, Patrick Marcel Seumo Tchekwagep, Ana Luiza Vilela Strapazon, Francesco Canfarotta, Alan Thomson, Joanna Czulak, Rhiannon E. Johnson, Katarina Novakovic, Patricia Losada-Pérez, Azfar Zaman, et al.

    We demonstrate that a novel functionalized interface, where molecularly imprinted polymer nanoparticles (nanoMIPs) are attached to screen-printed graphite electrodes (SPEs), can be utilized for the thermal detection of the cardiac biomarker troponin I (cTnI). The ultrasensitive detection of the unique protein cTnI can be utilized for the early diagnosis of myocardial infraction (i.e., heart attacks), resulting in considerably lower patient mortality and morbidity. Our developed platform presents an innovative route to develop accurate, low-cost, and disposable sensors for the diagnosis of cardiovascular diseases, specifically myocardial infraction. A reproducible and advantageous solid-phase approach was utilized to synthesize high-affinity nanoMIPs (average size = 71 nm) for cTnI, which served as synthetic receptors in a thermal sensing platform. To assess the performance and commercial potential of the sensor platform, various approaches were used to immobilize nanoMIPs onto thermocouples or SPEs: dip coating, drop casting, and a covalent approach relying on electrografting with an organic coupling reaction. Characterization of the nanoMIP-functionalized surfaces was performed with electrochemical impedance spectroscopy, atomic force microscopy, and scanning electron microscopy. Measurements from an in-house designed thermal setup revealed that covalent functionalization of nanoMIPs onto SPEs led to the most reproducible sensing capabilities. The proof of application was provided by measuring buffered solutions spiked with cTnI, which demonstrated that through monitoring changes in heat transfer at the solid–liquid interface, we can measure concentrations as low as 10 pg L–1, resulting in the most sensitive test of this type. Furthermore, preliminary data are presented for a prototype platform, which can detect cTnI with shorter measurement times and smaller sample volumes. The excellent sensor performance, versatility of the nanoMIPs, and reproducible and low-cost nature of the SPEs demonstrate that this sensor platform technology has a clear commercial route with high potential to contribute to sustainable healthcare.


  • Negative selection of MIPs to create high specificity ligands for glycated haemoglobin

    by Katarzyna Smolinska-Kempisty, Antonio Guerreiro, Joanna Czulak, Sergey Piletsky


  • Thermal Detection of Cardiac Biomarkers Heart-Fatty Acid Binding Protein and ST2 Using a Molecularly Imprinted Nanoparticle-Based Multiplex Sensor Platform

    by Robert D. Crapnell, Francesco Canfarotta, Joanna Czulak, Rhiannon Johnson, Kai Betlem, Francesco Mecozzi, Michael P. Down, Kasper Eersels, Bart van Grinsven, Thomas J. Cleij, et al.

    This manuscript describes the production of Molecularly Imprinted Polymer nanoparticles (nanoMIPs) for the cardiac biomarkers heart-fatty acid binding protein (H-FABP) and ST2 by solid-phase synthesis, and their use as synthetic antibodies in a multiplexed sensing platform. Analysis by Surface Plasmon Resonance (SPR) shows that the affinity of the nanoMIPs is similar to that of commercially available antibodies. The particles are coated onto the surface of thermo-couples and inserted into 3D-printed flow cells of different multiplexed designs. We demonstrate it is possible to selectively detect both cardiac biomarkers within the physiologically relevant range. Furthermore, the developed sensor platform is the first example of a multiplex format of this thermal analysis technique which enables simultaneous measurements of two different compounds with minimal cross selectivity. The format where three thermocouples are positioned in parallel exhibits the highest sensitivity, which is explained by modelling the heat flow distribution with-in the flow cell. This design is used in further experiments and proof-of-application of the sensor platform is provided by measuring spiked fetal bovine serum samples. Due to the high selectivity, short measurement time, and low-cost of this array format, it provides an interesting alternative to traditional immunoassays. The use of nanoMIPs enables a multi-marker strategy, which has the potential to contribute to sustainable healthcare by improving reliability of cardiac biomarker testing.


  • Open Access

    New protocol for optimisation of polymer composition for imprinting of peptides and proteins

    by Thomas S. Bedwell, Nadeem Anjum, Yifeng Ma, Joanna Czulak, Alessandro Poma, Elena Piletska, Michael J. Whitcombe, Sergey A. Piletsky

    We present here a novel screening tool for optimisation of polymerisation mixtures used in imprinting of peptides and proteins. To facilitate rapid synthesis and screening of a combinatorial library of polymers the solid-phase synthesis method developed by Piletsky and co-workers was scaled down to 50 mg of template-immobilised solid phase, allowing a single well of a 96-well microplate to function as an individual reaction vessel. In this way, 32 different polymer compositions containing N-isopropylacrylamide, acrylic acid, N-(3-aminopropyl)methacrylamide hydrochloride, and N-tert-butylacrylamide, were tested in imprinting of three peptides and three proteins. Utilising filtration microplates has allowed the elution and washing steps to be performed in a similar manner to the large-scale synthesis, whilst incorporation of a fluorescent monomer (N-fluoresceinylacrylamide) made it possible to analyse the binding of synthesised polymer nanoparticles to the solid phase with immobilised templates under different washing conditions. The experiment has proven that the variations in monomer compositions had an effect on the yield and affinity of synthesised molecularly imprinted polymers for the peptides, but not for the proteins. Imprinting in this way presents an ideal method for performing small-scale syntheses for testing polymerisation mixtures, as information regarding the molecularly imprinted polymers affinity can be assessed as part of the elution process, without a need for time-consuming analysis such as quartz crystal microbalance or surface plasmon resonance.


  • Application of molecularly imprinted polymer nanoparticles for degradation of the bacterial autoinducerN-hexanoyl homoserine lactone

    by J. Garcia Lopez, E. V. Piletska, M. J. Whitcombe, J. Czulak, S. A. Piletsky

    A novel bacterial quorum quenching system is presented. For the first time the degradation of N-L-hexanoyl homoserine lactone (C6-AHL), a Gram-negative quorum sensing autoinducer, has been enhanced using molecularly imprinted nanoparticles (MIP NPs) which were prepared using transition state analogue of the γ-lactone ring hydrolysis as template.


  • Highly Efficient Abiotic Assay Formats for Methyl Parathion: Molecularly Imprinted Polymer Nanoparticle Assay as an Alternative to Enzyme-Linked Immunosorbent Assay

    by Cem Esen, Joanna Czulak, Todd Cowen, Elena Piletska, Sergey A. Piletsky

    Enzyme-linked immunosorbent assay (ELISA) is a widely used standard method for sensitive detection of analytes of environmental, clinical or biotechnological interest. However, ELISA has clear drawbacks related to the use of relatively unstable antibodies and enzyme conjugates, and need in several steps such as washing of non-bound conjugates and add-ing dye reagents. Herein we introduce a new completely abiotic assay where antibodies and enzymes are replaced with fluorescent molecularly imprinted polymer nanoparticles (nanoMIPs) and target-conjugated magnetic nanoparticles, which acted as both reporter probes and binding agents. The components of the molecularly imprinted polymer nanoparticles assay (MINA) are assembled in microtiter plates fitted with magnetic inserts. We have compared the performance of the new magnetic assay with MIP-based ELISA for the detection of methyl parathion (MP). Both assays have shown high sensitivity toward allowing detection of MP at picomolar concentrations without any cross reactivity against chlorpyriphos and fenthion. The fully abiotic assays were also proven to detect analyte in real samples such as tap water and milk. Unlike ELISA-based systems the novel assay required no washing steps or addition of enzyme substrates, making it more user-friendly and suitable for high throughput screening.


  • Novel assay format for proteins based on magnetic molecularly imprinted polymer nanoparticles—detection of pepsin

    by Elena V. Piletska, Joanna Czulak, Stanislav S. Piletsky, Antonio Guerreiro, Francesco Canfarotta

    A novel, abiotic assay format for the quantification of pepsin has been developed featuring replacement of conventional antibody binders and enzyme reporters with entirely synthetic alternatives. The assay was based on the application of magnetic molecularly imprinted polymer nanoparticles (MIP NPs) in an enzyme-linked immunosorbent assay format, where colored or fluorescent polystyrene beads serve as a label instead of enzyme. Modification of the standard microtiter plate with magnetic inserts permits the instantaneous immobilization of magnetic MIPs, with a hole in the middle of each insert allowing unobstructed measurement of the sample. The magnetic MIP NPs were synthetized using a solid-phase synthesis method in which pepsin, which was chosen as a model protein target present in “gastric juice”, was used as a template. The results suggested that blue polystyrene particles with 10 μm diameter combined with magnetic MIP NPs and magnetic inserts can be used for reliable detection of pepsin in the concentration range between 10 and 50 µg mL−1 in model solutions of pepsin. In order to measure pepsin in the “gastric juice” which constitutes a 100 mM solution of hydrochloric acid, the blue colored polystyrene beads were replaced with red fluorescent polystyrene beads that allowed precise measurement of clinical samples in nanomolar range following 10-fold dilution with buffer. This sensitivity, which was achieved using fluorescent polystyrene beads, permits quantifiable measurement of pepsin in the physiological range of concentrations between 5 and 50 μg mL−1. Furthermore, the technology and protocols presented here are transferable and can be applied to identify proteins in a wide range of clinical, forensic and environmental samples, using stable synthetic binders and reporters.


  • Open Access

    A Novel Assay Format as an Alternative to ELISA: MINA Test for Biotin

    by Stanislav S. Piletsky, Anthony E. G. Cass, Elena V. Piletska, Joanna Czulak

    A novel abiotic assay based on biotin‐specific fluorescent molecularly imprinted polymer nanoparticles (nanoMIPs) which acted as both reporter probes and binding agents, was developed. This is a first report of an assay which, unlike ELISA, required no washing steps or addition of enzyme substrates, making it more user‐friendly. The components of the molecularly imprinted polymer nanoparticles assay (MINA) were assembled in microtiter plates fitted with magnetic inserts. The fluorescent nanoMIPs were bound to biotin‐conjugated magnetic particles, which were attracted to the inserts. The addition of free biotin caused a displacement of the fluorescent nanoMIPs into solution, generating a signal proportional to the concentration of biotin. The nanoMIPs had a dissociation constant (Kd) of 14 nM, allowing the assay to detect biotin at nano‐molar concentrations. The pre‐assembled assay only required the addition of the sample and measurement of the fluorescence, and it functioned well after six weeks of storage without refrigeration. The assay did not show the susceptibility to several compounds which are known to interfere with avidin and streptavidin‐based assays, such as mercaptoethanol and sugars. The protocols optimized in this work could be used to develop the abiotic assays for any other compound of interest.


  • Open Access

    A novel thermal detection method based on molecularly imprinted nanoparticles as recognition elements

    by Francesco Canfarotta, J. Czulak, K. Betlem, A. Sachdeva, K. Eersels, B. van Grinsven, T. J. Cleij, M. Peeters

    Molecularly Imprinted Polymers (MIPs) are synthetic receptors that are able to selectively bind their target molecule and, for this reason, they are currently employed as recognition elements in sensors. In this work, MIP nanoparticles (nanoMIPs) are produced by solid-phase synthesis for a range of templates with different sizes, including a small molecule (biotin), two peptides (one derived from the epithelial growth factor receptor and vancomycin) and a protein (trypsin). NanoMIPs are then dipcoated on the surface of thermocouples that measure the temperature inside a liquid flow cell. Binding of the template to the MIP layer on the sensitive area of the thermocouple tip blocks the heat-flow from the sensor to the liquid, thereby lowering the overall temperature measured by the thermocouple. This is subsequently correlated to the concentration of the template, enabling measurement of target molecules in the low nanomolar regime. The significant improvement in the limit of detection (a magnitude of three orders compared to previously used MIP microparticles) can be attributed to their high affinity, enhanced conductivity and increased surface-to-volume ratio. It is the first time that these nanosized recognition elements are used in combination with thermal detection, and it is the first report on MIP-based thermal sensors for determining protein levels. The developed thermal sensors have a high selectivity, fast measurement time (in real-time. The set of biomolecules discussed in this manuscript show that it is possible to cover a range of template molecules regardless of their size, demonstrating the general applicability of the biosensor platform. In addition, with its high commercial potential and biocompatibility of the MIP receptor layer, this is an important step towards sensing assays for diagnostic applications that can be used in vivo.